Milrinone or Dobutamine for Cardiogenic Shock?

September 27, 2021 00:25:40
Milrinone or Dobutamine for Cardiogenic Shock?
Critical Care Perspectives in Emergency Medicine
Milrinone or Dobutamine for Cardiogenic Shock?

Sep 27 2021 | 00:25:40

/

Show Notes

Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.  In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock.  Which agent was the winner?

You can get CME credit for this episode hereClick here for CME Account Creation Instructions

Other Episodes

Episode 0

March 26, 2018 00:31:51
Episode Cover

Managing Acute on Chronic Liver Failure

These are some of the sickest patients you’ll see in the ED and ICU. In this episode, we discuss incredibly useful pearls and pitfalls...

Listen

Episode 0

April 27, 2020 00:22:04
Episode Cover

Vasopressors & The Older Patient - The 65 Trial

Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic...

Listen

Episode 0

July 07, 2023 00:28:56
Episode Cover

VL versus DL...And The Winner Is?

Over 1 million critically ill patients undergo intubation each year in the United States.  Though direct laryngoscopy remains the most common technique worldwide for...

Listen